Search by Drug Name or NDC
NDC 59676-0580-15 Janssen COVID-19 Vaccine 50000000000 {VP}/.5mL Details
Janssen COVID-19 Vaccine 50000000000 {VP}/.5mL
Janssen COVID-19 Vaccine is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Janssen Products, LP. The primary component is AD26.COV2.S.
MedlinePlus Drug Summary
What is COVID-19? COVID-19 disease is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory (lung) illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever, chills, cough, shortness of breath, fatigue, muscle or body aches, headache, loss of taste or smell, sore throat, congestion, runny nose, nausea, vomiting, or diarrhea.
Related Packages: 59676-0580-15Last Updated: 12/01/2022
MedLinePlus Full Drug Details: COVID-19 Vaccine, Viral Vector (Janssen [Johnson and Johnson])
Product Information
| NDC | 59676-0580 |
|---|---|
| Product ID | 59676-580_a2cc90c9-fc7a-42c6-a28f-c3a7bfd54a01 |
| Associated GPIs | 17100002101840 |
| GCN Sequence Number | 081779 |
| GCN Sequence Number Description | COVID-19 vac,Ad26(Janssen)/PF VIAL 0.5 ML INTRAMUSC |
| HIC3 | Z0L |
| HIC3 Description | COVID-19 VACCINES |
| GCN | 48997 |
| HICL Sequence Number | 047034 |
| HICL Sequence Number Description | COVID-19 VAC, AD26.COV2.S (JANSSEN)/PF |
| Brand/Generic | Brand |
| Proprietary Name | Janssen COVID-19 Vaccine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ad26.COV2.S |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SUSPENSION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 50000000000 |
| Active Ingredient Units | {VP}/.5mL |
| Substance Name | AD26.COV2.S |
| Labeler Name | Janssen Products, LP |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | EMERGENCY USE AUTHORIZATION |
| Application Number | n/a |
| Listing Certified Through | 2023-12-31 |
Package
NDC 59676-0580-15 (59676058015)
| NDC Package Code | 59676-580-15 |
|---|---|
| Billing NDC | 59676058015 |
| Package | 10 VIAL, MULTI-DOSE in 1 CARTON (59676-580-15) / 2.5 mL in 1 VIAL, MULTI-DOSE (59676-580-05) |
| Marketing Start Date | 2021-01-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |